Lumos Pharma Inc (LUMO)
4.31
-0.02
(-0.46%)
USD |
NASDAQ |
Nov 22, 15:41
Lumos Pharma Total Liabilities (Quarterly): 12.55M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.55M |
| June 30, 2024 | 11.08M |
| March 31, 2024 | 10.64M |
| December 31, 2023 | 13.33M |
| September 30, 2023 | 12.26M |
| June 30, 2023 | 12.71M |
| March 31, 2023 | 11.21M |
| December 31, 2022 | 12.71M |
| September 30, 2022 | 11.50M |
| June 30, 2022 | 10.91M |
| March 31, 2022 | 11.37M |
| December 31, 2021 | 11.34M |
| September 30, 2021 | 12.34M |
| June 30, 2021 | 13.15M |
| March 31, 2021 | 11.09M |
| December 31, 2020 | 12.46M |
| September 30, 2020 | 17.65M |
| June 30, 2020 | 55.73M |
| March 31, 2020 | 61.42M |
| December 31, 2019 | 64.99M |
| September 30, 2019 | 20.26M |
| June 30, 2019 | 22.12M |
| March 31, 2019 | 22.25M |
| December 31, 2018 | 15.80M |
| September 30, 2018 | 17.12M |
| Date | Value |
|---|---|
| June 30, 2018 | 23.07M |
| March 31, 2018 | 27.08M |
| December 31, 2017 | 29.14M |
| September 30, 2017 | 33.25M |
| June 30, 2017 | 33.52M |
| March 31, 2017 | 35.27M |
| December 31, 2016 | 45.28M |
| September 30, 2016 | 48.07M |
| June 30, 2016 | 30.10M |
| March 31, 2016 | 23.11M |
| December 31, 2015 | 22.77M |
| September 30, 2015 | 19.41M |
| June 30, 2015 | 17.49M |
| March 31, 2015 | 26.30M |
| December 31, 2014 | 34.28M |
| September 30, 2014 | 15.49M |
| June 30, 2014 | 12.07M |
| March 31, 2014 | 11.92M |
| December 31, 2013 | 12.23M |
| September 30, 2013 | 13.54M |
| June 30, 2013 | 12.66M |
| March 31, 2013 | 11.66M |
| December 31, 2012 | 11.50M |
| September 30, 2012 | 11.78M |
| June 30, 2012 | 10.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.64M
Minimum
Mar 2024
64.99M
Maximum
Dec 2019
19.52M
Average
12.40M
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| Calidi Biotherapeutics Inc | 16.46M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.46M |
| Shareholders Equity (Quarterly) | 4.914M |
| Current Ratio | 2.656 |